Orthofix Medical Inc (OFIX)

Orthofix Medical Inc. experienced recent insider trading activity characterized by two executive sales totaling approximately $68,849. These transactions occurred following a period where the stock price declined by 11.9% over ninety days. The company's last results financiers report showed a 15.2% earnings beat, yet shares remain near their annual lows.
Ticker: OFIX Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Orthofix Medical Inc. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Sale 18 Jun 2026
Value US$1,381,079.58 | Price 102.81 | Shares 66,946 (+32.2%)
Sale 18 Jun 2026
Value US$774,651.57 | Price 491.26 | Shares 58,435 (+4.1%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-22 2026-06-18 S Sale

Pres, Global Ops & Qual

Officer
66,946 +32.2%
102.81
US$1,381,080
66,946 +32.2% 102.81 US$1,381,080
2026-06-22 2026-06-18 S Sale

Pres, Global Ops & Qual

Officer
58,435 +4.1%
491.26
US$774,652
58,435 +4.1% 491.26 US$774,652
2026-05-08 2026-05-07 B Purchase Non-Executive Director
27,912 +49.2%
270.39
US$659,878
27,912 +49.2% 270.39 US$659,878
2026-05-07 2026-05-07 B Purchase Large shareholder
904 +0.2%
12.15
US$10,981
904 +0.2% 12.15 US$10,981
2026-05-07 2026-05-07 B Purchase Large shareholder
1,808 +0.5%
12.20
US$22,053
1,808 +0.5% 12.20 US$22,053
2026-05-07 2026-05-07 B Purchase Large shareholder
9,096 +0.2%
12.15
US$110,490
9,096 +0.2% 12.15 US$110,490
2026-05-07 2026-05-07 B Purchase Large shareholder
18,192 +0.5%
12.20
US$221,901
18,192 +0.5% 12.20 US$221,901
2026-05-07 2026-05-06 B Purchase Large shareholder
3,792 +1.0%
12.23
US$46,369
3,792 +1.0% 12.23 US$46,369
2026-05-07 2026-05-06 B Purchase Large shareholder
38,154 +1.0%
12.23
US$466,547
38,154 +1.0% 12.23 US$466,547
2026-05-07 2026-05-05 B Purchase Large shareholder
2,911 +0.8%
11.99
US$34,911
2,911 +0.8% 11.99 US$34,911
2026-05-07 2026-05-05 B Purchase Large shareholder
110,039 +3.0%
11.99
US$1,319,676
110,039 +3.0% 11.99 US$1,319,676
2026-04-20 2026-04-16 S Sale

CLO

Officer
3,743 -6.0%
12.82
US$47,985
3,743 -6.0% 12.82 US$47,985
2026-03-19 2026-03-17 S Sale

CP&BOO

Officer
4,269 -2.6%
11.92
US$50,886
4,269 -2.6% 11.92 US$50,886
2026-03-10 2026-03-10 B Purchase Non-Executive Director
2,400 +9.5%
12.45
US$29,880
2,400 +9.5% 12.45 US$29,880
2026-03-10 2026-03-10 B Purchase Non-Executive Director
100 +0.4%
12.44
US$1,244
100 +0.4% 12.44 US$1,244
2026-03-10 2026-03-09 B Purchase Non-Executive Director
2,500 +11.1%
12.48
US$31,200
2,500 +11.1% 12.48 US$31,200
2026-03-06 2026-03-05 S Sale

CFO

Officer
2,363 -2.6%
12.55
US$29,658
2,363 -2.6% 12.55 US$29,658
2026-03-06 2026-03-05 S Sale

CP&BOO

Officer
1,141 -0.7%
12.55
US$14,320
1,141 -0.7% 12.55 US$14,320
2026-03-06 2026-03-05 S Sale

President & CEO

Executive Director
6,031 -1.8%
12.55
US$75,694
6,031 -1.8% 12.55 US$75,694
2026-03-06 2026-03-05 S Sale

President, Global Limb Recon

Officer
758 -1.5%
12.55
US$9,514
758 -1.5% 12.55 US$9,514
2026-03-06 2026-03-05 S Sale

Pres, Global Ops & Qual

Officer
1,263 -1.8%
12.55
US$15,852
1,263 -1.8% 12.55 US$15,852
2026-03-06 2026-03-05 S Sale

President, Global Spine

Officer
1,053 -4.0%
12.55
US$13,216
1,053 -4.0% 12.55 US$13,216
2026-03-06 2026-03-05 S Sale

CLO

Officer
1,370 -2.1%
12.55
US$17,195
1,370 -2.1% 12.55 US$17,195
2026-03-06 2026-03-04 S Sale

CFO

Officer
2,425 -2.6%
12.92
US$31,322
2,425 -2.6% 12.92 US$31,322
2026-03-06 2026-03-04 S Sale

CP&BOO

Officer
1,171 -0.7%
12.92
US$15,125
1,171 -0.7% 12.92 US$15,125
2026-03-06 2026-03-04 S Sale

President & CEO

Executive Director
6,189 -1.9%
12.92
US$79,939
6,189 -1.9% 12.92 US$79,939
2026-03-06 2026-03-04 S Sale

President, Global Limb Recon

Officer
778 -1.5%
12.92
US$10,049
778 -1.5% 12.92 US$10,049
2026-03-06 2026-03-04 S Sale

Pres, Global Ops & Qual

Officer
1,296 -1.8%
12.92
US$16,740
1,296 -1.8% 12.92 US$16,740
2026-03-06 2026-03-04 S Sale

President, Global Spine

Officer
1,080 -3.9%
12.92
US$13,950
1,080 -3.9% 12.92 US$13,950
2026-03-06 2026-03-04 S Sale

CLO

Officer
1,405 -2.1%
12.92
US$18,147
1,405 -2.1% 12.92 US$18,147
2026-02-26 2026-02-25 B Purchase Large shareholder
3,102 +0.8%
12.96
US$40,212
3,102 +0.8% 12.96 US$40,212
2026-02-26 2026-02-25 B Purchase Large shareholder
9,959 +0.3%
12.96
US$129,103
9,959 +0.3% 12.96 US$129,103
2026-02-26 2026-02-24 B Purchase Large shareholder
7,721 +2.1%
12.55
US$96,864
7,721 +2.1% 12.55 US$96,864
2026-02-26 2026-02-24 B Purchase Large shareholder
117,076 +3.3%
12.55
US$1,468,777
117,076 +3.3% 12.55 US$1,468,777
2026-01-21 2026-01-16 S Sale

CFO

Officer
4,873 -7.7%
14.38
US$70,074
4,873 -7.7% 14.38 US$70,074
2026-01-13 2026-01-12 S Sale

President & CEO

Executive Director
9,797 -4.3%
15.21
US$149,050
9,797 -4.3% 15.21 US$149,050
2026-01-13 2026-01-09 S Sale

President & CEO

Executive Director
9,600 -4.1%
15.82
US$151,906
9,600 -4.1% 15.82 US$151,906
2025-08-20 2025-08-18 S Sale

President, Global Orthopedics

Officer
1,996 -6.2%
14.21
US$28,363
1,996 -6.2% 14.21 US$28,363
2025-07-07 2025-07-02 B Purchase Large shareholder
1,250 +0.0%
11.11
US$13,881
1,250 +0.0% 11.11 US$13,881
2025-06-23 2025-06-18 S Sale

Pres, Global Ops & Qual

Officer
3,728 -7.4%
10.51
US$39,181
3,728 -7.4% 10.51 US$39,181
2025-06-13 2025-06-11 S Sale

President, Global Spine

Officer
1,643 -5.6%
11.64
US$19,125
1,643 -5.6% 11.64 US$19,125
2025-06-05 2025-06-04 B Purchase Non-Executive Director
2,250 +7.8%
10.92
US$24,570
2,250 +7.8% 10.92 US$24,570
2025-05-12 2025-05-12 B Purchase Non-Executive Director
2,000 +7.5%
12.59
US$25,172
2,000 +7.5% 12.59 US$25,172
2025-05-12 2025-05-09 B Purchase

President & CEO

Executive Director
10,000 +4.5%
12.54
US$125,400
10,000 +4.5% 12.54 US$125,400
2025-05-12 2025-05-09 B Purchase Non-Executive Director
1,990 +8.0%
12.62
US$25,120
1,990 +8.0% 12.62 US$25,120
2025-05-08 2025-05-07 B Purchase Large shareholder
8,519 +2.4%
12.31
US$104,869
8,519 +2.4% 12.31 US$104,869
2025-05-08 2025-05-07 B Purchase Large shareholder
8,106 +2.4%
12.31
US$99,785
8,106 +2.4% 12.31 US$99,785
2025-05-08 2025-05-07 B Purchase Large shareholder
83,375 +2.4%
12.31
US$1,026,346
83,375 +2.4% 12.31 US$1,026,346
2025-04-18 2025-04-16 S Sale

CLO

Officer
3,816 -8.2%
13.31
US$50,791
3,816 -8.2% 13.31 US$50,791
2025-04-04 2025-04-02 S Sale

CAO

Officer
76 -0.2%
15.74
US$1,196
76 -0.2% 15.74 US$1,196
2025-03-20 2025-03-18 S Sale

CAO

Officer
296 -0.7%
16.60
US$4,914
296 -0.7% 16.60 US$4,914
2025-03-20 2025-03-18 S Sale

CP&BOO

Officer
4,287 -3.1%
16.60
US$71,164
4,287 -3.1% 16.60 US$71,164
2025-03-06 2025-03-05 B Purchase

President & CEO

Executive Director
9,914 +4.7%
17.43
US$172,801
9,914 +4.7% 17.43 US$172,801
2025-02-05 2025-02-04 S Sale

CAO

Officer
187 -0.5%
18.08
US$3,381
187 -0.5% 18.08 US$3,381
2025-02-05 2025-02-03 S Sale

CAO

Officer
767 -1.9%
17.79
US$13,645
767 -1.9% 17.79 US$13,645
2025-01-21 2025-01-16 S Sale

CFO

Officer
4,655 -14.1%
17.89
US$83,278
4,655 -14.1% 17.89 US$83,278
2025-01-14 2025-01-13 S Sale

CAO

Officer
227 -0.6%
17.14
US$3,891
227 -0.6% 17.14 US$3,891
2025-01-14 2025-01-13 S Sale

President & CEO

Executive Director
9,203 -6.9%
17.14
US$157,757
9,203 -6.9% 17.14 US$157,757
2025-01-14 2025-01-10 S Sale

CAO

Officer
248 -0.6%
16.83
US$4,174
248 -0.6% 16.83 US$4,174
2025-01-14 2025-01-10 S Sale

President & CEO

Executive Director
10,078 -7.0%
16.83
US$169,619
10,078 -7.0% 16.83 US$169,619
2025-01-10 2025-01-08 S Sale

CAO

Officer
238 -0.6%
16.97
US$4,039
238 -0.6% 16.97 US$4,039
2025-01-10 2025-01-07 S Sale

CAO

Officer
238 -0.6%
17.14
US$4,078
238 -0.6% 17.14 US$4,078
2024-12-19 2024-12-17 S Sale

CAO

Officer
26 -0.1%
17.84
US$464
26 -0.1% 17.84 US$464
2023-12-21 2023-12-18 PrS Proposed sale

Director

Non-Executive Director
66,665
13.89
US$925,975
66,665 13.89 US$925,975
2023-11-20 2023-11-20 PrS Proposed sale

Officer

Officer
33,456
11.00
US$368,027
33,456 11.00 US$368,027
2023-11-09 2023-11-09 PrS Proposed sale

Officer

Officer
9,084
10.80
US$98,110
9,084 10.80 US$98,110
2023-11-09 2023-11-09 PrS Proposed sale

Officer

Officer
28,985
11.00
US$318,835
28,985 11.00 US$318,835
2023-09-14 2023-09-14 B Purchase Non-Executive Director
7,500 +9.5%
13.47
US$101,025
7,500 +9.5% 13.47 US$101,025
2023-05-26 2023-05-26 S Sale

President of Global Spine

Officer
3,876 -2.6%
19.00
US$73,644
3,876 -2.6% 19.00 US$73,644
2023-05-26 2023-05-24 S Sale

President of Global Spine

Officer
4,367 -2.9%
19.00
US$82,973
4,367 -2.9% 19.00 US$82,973
2023-05-24 2023-05-24 PrS Proposed sale

Officer

Officer
10,119
19.00
US$192,261
10,119 19.00 US$192,261
2023-04-05 2023-03-10 S Sale Non-Executive Director
4,262 -17.5%
17.75
US$75,650
4,262 -17.5% 17.75 US$75,650
2021-11-22 2021-11-22 B Purchase Non-Executive Director
2,000 +8.0%
31.15
US$62,300
2,000 +8.0% 31.15 US$62,300
2021-11-19 2021-11-19 B Purchase Non-Executive Director
1,660 +26.4%
30.27
US$50,248
1,660 +26.4% 30.27 US$50,248
2021-11-19 2021-11-19 B Purchase

CFO

Officer
1,400 +1.9%
30.05
US$42,070
1,400 +1.9% 30.05 US$42,070